Cleared Traditional

K832076 - ELECTRONIC BLOOD PRESS. METER EN-212

K832076 is the FDA 510(k) clearance for ELECTRONIC BLOOD PRESS. METER EN-212 by Panasonic Co. Div. Matsu Elec. Corp. America. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Traditional 510(k) pathway after a 486-day FDA review.

K832076 · Panasonic Co. Div. Matsu Elec. Corp. America · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1984
Decision
486d
Days
Class 2
Risk

K832076 is an FDA 510(k) clearance for the ELECTRONIC BLOOD PRESS. METER EN-212. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Panasonic Co. Div. Matsu Elec. Corp. America (Walker, US). The FDA issued a Cleared decision on October 26, 1984 after a review of 486 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Panasonic Co. Div. Matsu Elec. Corp. America devices

Submission Details

510(k) Number K832076 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 28, 1983
Decision Date October 26, 1984
Days to Decision 486 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
361d slower than avg
Panel avg: 125d · This submission: 486d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 537
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K832076.
DINAMAP VITAL SIGNS MONITOR 1846 SX & 1846P SX
K844839 · Critikon Company, LLC · Apr 1985
ACCUTORR CSM SYSTEM
K842538 · Datascope Corp. · Mar 1985
MUSE-DP
K840932 · Marquette Electronics, Inc. · Oct 1984
NON-INVASIVE BP MODULE 7000
K841336 · Marquette Electronics, Inc. · Oct 1984
DRAGER SPHYGMOMED
K840162 · Draeger Medical, Inc. · May 1984
TYCOS SELF CHECK BPM3 BLOOD PRESS MONI
K840469 · Sybron Corp. · May 1984